Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Some patchy mist and fog overnight as the temperature's dip.
The actor joined hundreds of mourners at the funeral of the 30-year-old make up artist in the village of Cappawhite, Ireland.
Odense zoo plans to publicly dissect a year-old lion - undeterred by outrage at giraffe who was killed in Copenhagen last year.